SpaceX (SPCX) stock: Britain confirms US$40 million Starshield contract, institutional positions exp

Disclaimer: Content does not constitute investment advice. Trading involves risks—please invest with caution!

Core Points

Institutional investors accelerate the deployment of SPCX (SpaceX-related stocks)
SpaceX's quarterly results exceeded market expectations
Britain became the first non-American country to publicly admit the deployment of the Starshield military satellite network, investing approximately US$40 million
The British Army currently deploys approximately 1,
Revenue for 2,000 Starshield terminals and 500 Starlink terminals reached US$7.81 billion in the second quarter, a year-on-year increase of 92%, exceeding earnings forecasts.
Many institutions, including IPG Investment Advisors, opened positions in SPCX in the second quarter
Wall Street analysts maintained a "moderate buy" consensus with a target price of US$221.06; The opening price on Thursday was US$147.55.

The UK was the first to publicly deploy the SpaceX Starshield military satellite network

Reuters revealed on Thursday that the UK became the first country outside the United States to publicly admit to deploying SpaceX's Starshield military-grade satellite network, and allocated nearly US$40 million to purchase the joint services of Starlink and Starshield. The news was released after the British Ministry of Defense responded to an information disclosure request.

Currently, the British military is using approximately 1,000 Starshield terminals and 500 Starlink terminals. Financial details show that approximately £ 13 million (approximately US$17.6 million) was spent on Starshield services and another £ 16.5 million was spent on Starlink services.

The UK began adopting Starlink technology in mid-2022, and then migrated critical military communications infrastructure to the Starshield platform after SpaceX restricted Starlink to non-combat uses such as morale support, welfare activities, entertainment and training exercises.

Although Starshield shares the same satellite network as Starlink, it operates through dedicated terminals and separate ground infrastructure. The service offers advanced encryption protocols, military-standard service-level agreements (SLAs), higher network priorities, and broader geographical coverage.

There is a significant cost difference between the two services. Starshield subscriptions for UK users range from £ 5500 per month (5TB data plan) to £ 25,000 per month (unlimited data access). In comparison, the traditional Starlink business plan costs £ 1,830 per month (2TB of data). Starshield terminal hardware costs between £ 4,000 and £ 7,000 per unit, which is at least twice the cost of Starlink's commercial equipment.

The UK purchased the first batch of dedicated Starshield terminals in 2025, and has previously accessed Starshield capacity through existing Starlink hardware since 2024. At the same time, New Zealand is also evaluating Starshield capabilities for potential military applications.

U.S. government agencies have committed more than $6 billion in funding through the multi-year Starshield contract, implemented primarily through two U.S. Space Force projects focusing on the low-Earth-orbit satellite network.

Institutional investors accelerate SPCX deployment

In terms of investment activity, IPG Investment Advisors purchased 11,561 SPCX shares in the second quarter, with a value of approximately $1.98 million. Other institutional investors have similarly established new positions. Hyperion Asset Management has established positions worth approximately $201 million, and K5 Global Advisor entered with shares worth nearly $6.59 billion. Wedbush Securities and Assenagon Asset Management both opened positions during this period.

SPCX opened at $147.55 on Thursday. The company's market value is US$1.93 trillion. The stock's 52-week trading range is $104.83 to $225.64, and its 50-day moving average is $135.28.

SpaceX's quarterly results exceeded expectations

SpaceX disclosed on August 4 that total revenue for the second quarter was US$7.81 billion, a year-on-year increase of 91.9%. Earnings per share loss of $0.09 was better than analysts 'expectations for a loss of $0.26 per share and a better performance of $0.17.

Pivotal Research recently released a research report, giving it a "buy" rating with a target price of US$220. Arete Research set a target price of $450. Barclays upgraded its rating to "overrated" from "underrated". CFRA maintains a "sell" rating with a target price of $115.

However, the stock still faces some challenges. After the recent lock-up period ended, approximately 319 million insider shares were available for sale on the market, with a value of approximately US$47 billion to US$49 billion. There is still uncertainty surrounding the execution of AI data center operations, with reports that some facilities are operating without backup power and a $920 million deadline for compliance obligations is approaching.

Analysts agreed to maintain a "moderate buy" rating with a price target of $221.06, according to MarketBeat data.